- •Familial hypercholesterolemia is very much under-reported in Saudi Arabia.
- •Its prevalence and molecular characteristics are not accurately described.
- •It is estimated that 55% of marriages in the country are within the same extended family.
- •Therefore, it is expected to have a higher occurrence than neighbouring countries due to high consanguinity marriages.
- •Existence of recessive and dominant forms of FH within the same family represents an important challenge for management.
Background and aims
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Hypercholesterolaemia, Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.Eur. Heart J. 2014; 35: 2146-2157
- LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.Int. Arch. Med. 2010; 3: 36
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.Eur. Heart J. 2013; 34 (3478–3490a)
- Homozygous autosomal dominant hypercholesterolaemia: prevalence, diagnosis, and current and future treatment perspectives.Curr. Opin. Lipidol. 2015; 26: 200-209
- US prevalence of familial hypercholesterolemia higher than expected. News and perspective.Cardilogy. 2016; (March 14)
- Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.Am. J. Epidemiol. 2004; 160: 407-420
- Identification of a novel nonsense variant c.1332dup, p. (D445*) in the LDLR gene that causes familial hypercholesterolemia.Hum. Genome Var. 2014; 1: 14021
- Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.Gene. 2015; 565: 76-84
- Identification of a recurrent frameshift mutation at the LDLR exon 14 (c.2027delG, p. (G676Afs*33)) causing familial hypercholesterolemia in Saudi Arab homozygous children.Genomics. 2016; 107: 24-32
- Compound heterozygous LDLR variant in severely affected familial hypercholesterolemia patient.Acta Biochim. Pol. 2017; 64: 75-79
- The spectrum of familial hypercholesterolemia (FH) in Saudi Arabia: prime time for patient FH registry, open cardiovasc.Med. J. 2017; 11: 66-75
- Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population.Acta Biochim. Pol. 2015; 62: 559-562
- Identification and treatment of patients with homozygous familial hypercholesterolaemia: information and recommendations from a Middle East advisory panel.Curr. Vasc. Pharmacol. 2015; 13: 759-770
- Regional variations in the prevalence of consanguinity in Saudi Arabia.Saudi Med. J. 2007; 28: 1881-1884
- Consanguinity and reproductive health among Arabs.Reprod. Health. 2009; 6: 17
- Siblings with normal LDL receptor activity and severe hypercholesterolemia.Arterioscler. Thromb. 1992; 12: 1071-1078
- Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein.Science. 2001; 292: 1394-1398
- Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison.Atherosclerosis. 2006; 188: 398-405
- A novel Thr56Met mutation of the autosomal recessive hypercholesterolemia gene associated with hypercholesterolemia.J. Atherosclerosis Thromb. 2010; 17: 131-140
- A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene.Atherosclerosis. 2011; 219: 663-666
- Scientific steering committee on behalf of the Simon Broome register group.BMJ. 1991; 303: 893-896
- Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.Nat. Protoc. 2009; 4: 1073-1081
- Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease.Gene. 2016; 591: 214-226
- CHARMM: the biomolecular simulation program.J. Comput. Chem. 2009; 30: 1545-1614
- GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation.J. Chem. Theor. Comput. 2008; 4: 435-447
- Comparison of simple potential functions for simulating liquid water.J. Chem. Phys. 1983; 79: 926-935
- DUET: a server for predicting effects of mutations on protein stability via an integrated computational approach.Nucleic Acids Res. 2014; 42: W314-W319
- An integrated map of genetic variation from 1,092 human genomes.Nature. 2012; 491: 56-65
- COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer.Nucleic Acids Res. 2010; 38: D652-D657
- Ensembl 2014.Nucleic Acids Res. 2014; 42: D749-D755
- A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia.Gene. 2013; 521: 200-203
- Variable expressivity and co-occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy.Mol. Genet. Genomic Med. 2016; 4: 283-291
- Familial hypercholesterolemia: developments in diagnosis and treatment.Dtsch Arztebl Int. 2014; 111: 523-529
- Novel LDLR variants in patients with familial hypercholesterolemia: in silico analysis as a tool to predict pathogenic variants in children and their families.Ann. Hum. Genet. 2013; 77: 426-434